Source comparison
MK-677 FDA Approved Status: Comparison Table
FDA-Approved Medication Completed Phase III trials, NDA approved, prescription available cGMP facilities with FDA batch inspection Licensed pharmacies with valid prescription Phase III RCTs + post-market surveillance Guaranteed potency, purity, and traceabilit
This comparison does not assign a generated winner or score.
- FDA-Approved Medication
- Completed Phase III trials, NDA approved, prescription available
- cGMP facilities with FDA batch inspection
- Licensed pharmacies with valid prescription
- Phase III RCTs + post-market surveillance
- Guaranteed potency, purity, and traceability; insurance coverage possible
- Investigational New Drug (MK-677's Current Status)
- Phase II complete, no NDA filed, research-only authorization
- Registered research suppliers under 21 CFR 312
- Research institutions with IRB approval only
- Phase II clinical trials (efficacy signals established)
- Legal only for research; no consumer safety guarantees; no prescription pathway
- Dietary Supplement (Illegal for MK-677)
- Not applicable. Compounds tested as drugs cannot be reclassified as supplements
- Minimal FDA oversight (cGMP voluntary)
- Retail stores, online sellers
- No clinical trial requirement
- FDA warning letters issued; products seized; sellers face enforcement
- Compounded Medication
- Prepared by licensed pharmacies from bulk APIs
- State pharmacy board + FDA 503B oversight
- Prescription required from licensed prescriber
- No independent clinical trials (relies on FDA-approved API)
- Not applicable to MK-677. No FDA-approved API exists to compound from